en
Feedback

Don't get caught by a cheater! Telemetrio finds and tags such channels 👉 If you want to see the tag, subscribe

Kasr Alainy Data (198)

Kasr Alainy Data (198)

Open in Telegram

🛑 قناة لنشر داتا الفرقة الأولى القصر العيني 198 🛑 للتواصل 👈 https://t.me/KASRR_199/280 القنوات المهمه 👈 https://t.me/KASR_198/430

Show more

📈 Analytical overview of Telegram channel Kasr Alainy Data (198)

Channel Kasr Alainy Data (198) (@data_ka198) in the English language segment is an active participant. Currently, the community unites 12 522 subscribers, ranking 16 221 in the Education category and 6 135 in the Saudi Arabia region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 12 522 subscribers.

According to the latest data from 18 October, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 342 over the last 30 days and by -1 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 7.53%. Within the first 24 hours after publication, content typically collects 2.76% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 943 views. Within the first day, a publication typically gains 346 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 0.
  • Thematic interests: Content is focused on key topics such as crash, المحاضرة, فيديو, pharma, لمشاهدة.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
“🛑 قناة لنشر داتا الفرقة الأولى القصر العيني 198 🛑 للتواصل 👈 https://t.me/KASRR_199/280 القنوات المهمه 👈 https://t.me/KASR_198/430”

Thanks to the high frequency of updates (latest data received on 19 October, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Education category.

12 522
Subscribers
-124 hours
+237 days
+34230 days
Attracting Subscribers
Oct '26
October '26
+180
in 0 channels
September '26
+377
in 3 channels
Get PRO
August '26
+199
in 1 channels
Get PRO
July '26
+145
in 1 channels
Get PRO
June '26
+266
in 6 channels
Get PRO
May '26
+172
in 8 channels
Get PRO
April '26
+171
in 1 channels
Get PRO
March '26
+226
in 1 channels
Get PRO
February '26
+110
in 1 channels
Get PRO
January '26
+295
in 4 channels
Get PRO
December '25
+566
in 3 channels
Get PRO
November '25
+692
in 3 channels
Get PRO
October '25
+698
in 2 channels
Get PRO
September '25
+1 065
in 2 channels
Get PRO
August '25
+510
in 1 channels
Get PRO
July '25
+277
in 1 channels
Get PRO
June '25
+331
in 4 channels
Get PRO
May '25
+313
in 3 channels
Get PRO
April '25
+307
in 3 channels
Get PRO
March '25
+211
in 1 channels
Get PRO
February '25
+321
in 1 channels
Get PRO
January '25
+307
in 1 channels
Get PRO
December '24
+396
in 1 channels
Get PRO
November '24
+703
in 1 channels
Get PRO
October '24
+1 587
in 2 channels
Get PRO
September '24
+2 844
in 0 channels
Date
Subscriber Growth
Mentions
Channels
19 October0
18 October+2
17 October+6
16 October+3
15 October+4
14 October+11
13 October+2
12 October+7
11 October+10
10 October+20
09 October+30
08 October+6
07 October+12
06 October+5
05 October+14
04 October+18
03 October+5
02 October+17
01 October+8
Channel Posts
Opioids.. Lec-1

2
Pharma by Dr.Abdullah Salah [310][18]
211
3
Main Book Urinary System.pdf
212
4
Patho Notes by Dr.Tarek [310][Urinary System]
211
5
Pharma-18.pdf
358
6
Lec.19 pharma.. 310.MP3
353
7
Pharma by Dr.Mousa [310][19]
353
8
Patho.Revision-1.pdf
351
9
Liver Part.2
348
10
Patho Revision by Dr.Tarek [310][7]
336
11
Micro-6.pdf
336
12
lec.6 bacteria micro 309.MP3
330
13
Micro by Dr.Hesham [Bacteria][6]
318
14
Lec22.Patho.pdf
315
15
lec.22 patho 310.MP3
304
16
Patho by Dr.Tarek [310][22]
265
17
Dr_Abdallah_Salah_CNS_Opioid_Agonists_&_Antagonists_2026.pdf
260
18
Pharma Notes by Dr.Abdullah Salah [310][Opioid Agonists & Antagonists]
252
19
MCQs Antiepileptics 2027.pdf
256
20
Pharma MCQ by Dr.Mousa [310][Antiepileptics]
245